Study to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid Tumors
A Phase 1 Dose Escalation and Expansion Study to Evaluate Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, and Anti-Tumor Activity of PF-07209960 in Participants With Advanced or Metastatic Solid Tumors
Category & Conditions: Cancer
Medicine: PF-07209960
ClinicalTrials.gov Identifier (NCT): NCT04628780
Protocol ID: C4011001
Open Plain Language Summary Result:
Click here